Nom du produit:4-(((Benzyloxy)carbonyl)amino)benzoic acid

IUPAC Name:4-{[(benzyloxy)carbonyl]amino}benzoic acid

CAS:5330-71-2
Formule moléculaire:C15H13NO4
Pureté:95%
Numéro de catalogue:CM322678
Poids moléculaire:271.27

Unité d'emballage Stock disponible Prix($) Quantité
CM322678-10g 3-4 Weeks ƩƻƏ
CM322678-25g 3-4 Weeks şƩŭ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:5330-71-2
Formule moléculaire:C15H13NO4
Point de fusion:-
Code SMILES:O=C(O)C1=CC=C(NC(OCC2=CC=CC=C2)=O)C=C1
Densité:
Numéro de catalogue:CM322678
Poids moléculaire:271.27
Point d'ébullition:
N° Mdl:MFCD00610465
Stockage:

Column Infos

Mitapivat
Jan. 03 2024, Agios announces Phase 3 ENERGIZE study of PYRUKYND (Mitapivat) met primary endpoint and both key secondary endpoints in adults with non-transfusion-dependent(NTD) alpha- or beta-thalassemia. The positive data showed Mitapivat’s potential to become the first oral therapy approved for NTD thalassemia.
Mitapivat is a pyruvate kinase activator indicated for the treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency in the US, and for the treatment of PK deficiency in adult patients in the EU. By activating and stabilizing mutant pyruvate kinase, Mitapivat targets the underlying enzymatic defect that causes chronic hemolysis and ineffective erythropoiesis in order to restore enzyme activity.

Related Products